Roujeau J C
Service de Dermatologie, Hôpital Henri Mondor, Université Paris XII, Créteil, France.
Arch Dermatol. 1996 Dec;132(12):1499-502.
The term pulse therapy refers to discontinuous intravenous infusion of very high doses of drugs over a short time. Methylprednisolone (and dexamethasone in some countries) is the glucocorticoid most frequently administered this way. Doses of each pulse are not standardized but are usually 10 to 20 mg per kilogram of body weight for methylprednisolone (250-1000 mg) and 2 to 5 mg per kilogram of body weight (50-200 mg) for dexamethasone. Single doses of 500 mg of methylprednisolone and 100 mg of dexamethasone are both considered equivalent to 625 mg of prednisone. These very high doses, sometimes termed megadoses, are usually given as intravenous infusions over 30 minutes to 1 hour daily or every other day for a total of 1 to 5 administrations. In most indications, pulse glucocorticoid therapy is accompanied and/or followed by the continuous administration of low- or intermediate-dose glucocorticoids and/or immunosuppressive agents.
脉冲疗法是指在短时间内间断静脉输注非常高剂量的药物。甲泼尼龙(在某些国家为地塞米松)是最常以这种方式给药的糖皮质激素。每次脉冲剂量并无标准化规定,但甲泼尼龙通常为每千克体重10至20毫克(250 - 1000毫克),地塞米松为每千克体重2至5毫克(50 - 200毫克)。单次500毫克甲泼尼龙和100毫克地塞米松均被认为等同于625毫克泼尼松。这些非常高的剂量,有时称为超大剂量,通常每天或隔天在30分钟至1小时内静脉输注,总共给药1至5次。在大多数适应症中,脉冲糖皮质激素治疗同时和/或之后会持续给予低剂量或中等剂量的糖皮质激素和/或免疫抑制剂。